Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 30, 2025 08:58 ET | Source: Research and Markets

United States Vitiligo Market Research Report 2025-2033 by Diseases Type, Treatment Type, End User, Regions and Company Analysis

Dublin, Oct. 30, 2025 (GLOBE NEWSWIRE) -- The "United States Vitiligo Market Report by Diseases Type, Treatment Type, End User, Regions and Company Analysis, 2025-2033" report has been added to ...
October 01, 2025 09:31 ET | Source: Research and Markets

2025 Dermatology Treatment and Care Market Analysis Report with Impact Analysis of US Tariffs Featuring Novartis, Pfizer, Amgen, GSK, F. Hoffmann-La Roche, J&J, AbbVie, Merck, Bayer, Sanofi

Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "Dermatology Treatment and Care Market With Impact Analysis of US Tariffs (2025 Edition)" report has been added to ResearchAndMarkets.com's...
August 12, 2025 11:36 ET | Source: Research and Markets

Chronic Hand Eczema Market Forecasts Report 2025-2035 | Emerging Markets, Safer Therapies, and Digital Health Solutions for Chronic Skin Conditions Spur Opportunities

Dublin, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The "Chronic Hand Eczema Market: Focus on Type, Treatment Type, and Country Analysis - Analysis and Forecast, 2025-2035" has been added to ...
July 23, 2025 04:08 ET | Source: Research and Markets

Atopic Dermatitis Market Forecast Report 2025-2034 | FDA Approval of Tralokinumab-Ldrm Stimulates Treatment Advances

Dublin, July 23, 2025 (GLOBE NEWSWIRE) -- The "Atopic Dermatitis Market Report and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering.The atopic dermatitis market...
May 28, 2025 09:20 ET | Source: Research and Markets

Vitiligo Market Growth Trends and Forecast Report 2025-2033 - Rising Awareness, Diagnostic Advances, Innovative Therapies, and Expanding Global Healthcare Access

Dublin, May 28, 2025 (GLOBE NEWSWIRE) -- The "Vitiligo Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering.The...
February 26, 2025 10:00 ET | Source: Derm-Biome Pharmaceuticals, Inc

Derm-Biome’s DB-007-5 is highly effective at treating atopic dermatitis and reducing itch in preclinical study, outperforming the current leading topical AD drug

VANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver-based biopharmaceutical company focused on skin health and healthy ageing, is pleased to...
November 25, 2024 10:00 ET | Source: Derm-Biome Pharmaceuticals, Inc

Derm-Biome Pharmaceuticals adds Dr. Jerry Tan, internationally renowned expert in acne and acne scarring, to its Scientific Advisory Board

VANCOUVER, British Columbia, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver-based biopharmaceutical company developing safe and highly effective topical treatments...
October 29, 2024 05:01 ET | Source: Research and Markets

Dermatology Treatment and Care Research Report 2024-2030 with Analyst Recommendations - Tapping into the Demand for Tailored Solutions / Focus on Expansion in Emerging Markets

Dublin, Oct. 29, 2024 (GLOBE NEWSWIRE) -- The "Global Dermatology Treatment and Care Market (2024 Edition): Analysis By Treatment Type (Skin Disease and Care, Hair Disease and Care), By Route of...
May 08, 2024 10:00 ET | Source: Derm-Biome Pharmaceuticals, Inc

Derm-Biome Pharmaceuticals and TransBIOtech awarded $450,000 Applied Research and Development (ARD) grant funding

VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based biopharmaceutical company focused on skin health and healthy aging, is pleased to...
April 16, 2024 16:05 ET | Source: Kamari Pharma

Kamari Pharma Announces Abstracts Accepted for Presentation at the 81st Annual Meeting of the Society for Investigative Dermatology

Late breaking poster presentation includes Phase 1b clinical trial results demonstrating the safety and preliminary efficacy of KM-001, a topical TRPV3 inhibitor, for the treatment of palmoplantar...